LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2.

In conclusion, we firstly uncovered that LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2, providing novel clues for the treatment improvement of AML. PMID: 32338183 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32338183?dopt=Abstract

Source: Cancer Biology and Therapy - April 25, 2020 Category: Cancer & Oncology Authors: Li H, Tian X, Wang P, Hu J, Qin R, Xu R, Liu K, Hao J, Tian N Tags: Cancer Biol Ther Source Type: research